Under construction – not a live service
Sign in
Taking people in EgyptPhase 2/3

Comparing Two Treatments to Prevent Bleeding from Swollen Veins in the Food Pipe

Compares carvedilol pills with banding procedure in adults with cirrhosis and high blood pressure.

Plain-language title generated from the registry record
Registry title: Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding

Key facts

Where
Tanta, EgyptSee the site
Phase
Phase 2/3

Where in Egypt

  • Sherief Abd-ElsalamTanta, EgyptTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Sherief Abd-Elsalam
Trial code
NCT04499898
Record updated
5 August 2020
Original description
Carvedilol versus endoscopic band ligation for primary prophylaxis of oesophageal variceal bleeding in cirrhotic patients with arterial hypertensionRead full original descriptionShow less

Randomized Controlled Trial of Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding in Cirrhotic Patients With Arterial Hypertension

Carvedilol versus endoscopic band ligation for primary prophylaxis of oesophageal variceal bleeding in cirrhotic patients with arterial hypertension

Inclusion: • Aged >18 years; Cirrhotic patients with arterial hypertension; Endoscopic evidence of medium/large-sized esophageal varices.

Exclusion: • History of variceal bleeding or previous primary prevention of varices; Portal vein thrombosis or previous porto-systemic shunts as TIPS; Patients on drugs affecting portal pressure (beta blockers, nitrates); Advanced cardiovascular disease including acute myocardial infarction, atrio-ventricular block, congestive heart failure, chronic peripheral ischemia, severe bradycardia; Patients with severe respiratory diseases (COPD, bronchial asthma); Uncontrolled diabetes mellitus; Renal impairment; Hepatocellular carcinoma; Allergy to carvedilol; Pregnancy or lactation.

ClinicalTrials.gov NCT04499898